Crestwood Advisors Group LLC Has $1.19 Million Stake in CVS Health Co. (NYSE:CVS)

Crestwood Advisors Group LLC decreased its position in shares of CVS Health Co. (NYSE:CVS) by 8.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 18,972 shares of the pharmacy operator’s stock after selling 1,786 shares during the period. Crestwood Advisors Group LLC’s holdings in CVS Health were worth $1,193,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new stake in shares of CVS Health during the third quarter worth approximately $32,000. First Community Trust NA grew its stake in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health during the third quarter valued at approximately $33,000. Finally, ORG Partners LLC grew its stake in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Barclays reduced their price objective on shares of CVS Health from $82.00 to $75.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Wells Fargo & Company reduced their price objective on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a research note on Monday. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $59.00 to $85.00 in a research note on Friday, October 4th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Nine research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $73.11.

CVS Health Stock Performance

Shares of CVS opened at $55.33 on Wednesday. The firm has a 50-day moving average of $59.51 and a 200-day moving average of $59.29. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a market cap of $69.60 billion, a PE ratio of 9.85, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter last year, the firm posted $2.21 EPS. The company’s quarterly revenue was up 2.6% on a year-over-year basis. As a group, equities analysts forecast that CVS Health Co. will post 6.41 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.81%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 47.33%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.